Research

FULL TEXT: Bold KW, Fucito LM, Corbin WR, DeMartini KS, Leeman RF, Kranzler HR, O'Malley SS. Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults. Exp Clin Psychopharmacol 2016; 24 (5): 367-375

FULL TEXT: Niciu MJ, Arias AJ. Targeted opioid receptor antagonists in the treatment of alcohol use disorders. CNS Drugs 2013; 27 (10): 777-87

FULL TEXT: Goh ET, Morgan MY. Review article: pharmacotherapy for alcohol dependence - the why, the way and there wherefore. Aliment Pharmacol Ther 2017; 45: 865-882.

FULL TEXT: Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, Oncken C. Targeted naltrexone for problem drinkers. J Clin Psychoharmacol 2009; 29 (4): 350-7.

Hernandez-Avila CA, Song C, Kuo L, Tennen H, Armeli S, Kranzler HR. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Alcohol Clin Exp Res. 2006; 30 (5): 860-5.

FULL TEXT: Pettinati HM, Anton RF, Willenbring ML. The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence. Pscychiatry 2006; 3 (10): 36-9

Kranzler HR, Armela S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R. Targeted naltrexone for early problem drinkers.  J Clin Psychoharmacol 2003; 23 (3): 294-304.

FULL TEXT: Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 2001; 36 (1): 2-10.

Pettinati HM, O'Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychoharmacol 2006; 26 (6): 610-25